Integrated BioPharma Balance Sheet Health
Financial Health criteria checks 6/6
Integrated BioPharma has a total shareholder equity of $19.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $26.2M and $6.6M respectively. Integrated BioPharma's EBIT is $795.0K making its interest coverage ratio -33.1. It has cash and short-term investments of $2.3M.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | -33.1x |
| Cash | US$2.27m |
| Equity | US$19.55m |
| Total liabilities | US$6.63m |
| Total assets | US$26.18m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: INBP's short term assets ($18.3M) exceed its short term liabilities ($6.0M).
Long Term Liabilities: INBP's short term assets ($18.3M) exceed its long term liabilities ($604.0K).
Debt to Equity History and Analysis
Debt Level: INBP is debt free.
Reducing Debt: INBP has no debt compared to 5 years ago when its debt to equity ratio was 352.3%.
Debt Coverage: INBP has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: INBP has no debt, therefore coverage of interest payments is not a concern.